Evaluation of diffusion-weighted MRI and (18F) fluorothymidine-PET biomarkers for early response assessment in patients with operable non-small cell lung cancer treated with neoadjuvant chemotherapy.

Dominic CarlinAlexander WellerGem KramerYan LiuJohn C WatertonArturo ChitiMartina SolliniA Joop de LangenMary E R O'BrienMaria UrbanowiczBart Km JacobsNandita M deSouza

Published in: BJR open (2019)

During treatment, ADC increase precedes size reductions, but does not reflect histopathological necrosis.

Keyphrases

diffusion weighted
neoadjuvant chemotherapy
contrast enhanced
computed tomography
magnetic resonance imaging
locally advanced
magnetic resonance
diffusion weighted imaging
lymph node
sentinel lymph node
positron emission tomography
pet ct
rectal cancer
squamous cell carcinoma
radiation therapy
newly diagnosed